NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

MOUNTAIN VIEW, Calif., Dec. 21, 2022 - NeuroPace (Nasdaq: NPCE) announced participation in the 41^st Annual J.P. Morgan Healthcare Conference in San Francisco on January 12^th, 2023, at 9:00 a.m. Pacific Time. A live webcast and archived recording of their presentation will be accessible on the company’s investor website. NeuroPace is dedicated to improving the lives of people with epilepsy through its innovative RNS System, the first brain-responsive platform for real-time treatment at the seizure source, potentially enhancing care for patients with drug-resistant epilepsy.

MOUNTAIN VIEW, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will be participating in the upcoming 41^st Annual J.P. Morgan Healthcare Conference in San Francisco, California.

Management is scheduled to present on Thursday, January 12^th, 2023 at 9:00 a.m. Pacific Time / 12:00 p.m. Eastern Time.

A live webcast of this event, as well as an archived recording, will be available on the “Investors” section of the company’s website at: https://investors.neuropace.com. 

About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

Investor Contact:
Philip Taylor
Gilmartin Group
investors@neuropace.com 

 

FAQ

When will NeuroPace present at the J.P. Morgan Healthcare Conference?

NeuroPace will present on January 12^th, 2023, at 9:00 a.m. Pacific Time.

Where can I watch the NeuroPace presentation?

The presentation will be available via live webcast on the Investors section of NeuroPace's website.

What is the focus of NeuroPace's product offerings?

NeuroPace focuses on transforming the lives of epilepsy patients through its RNS System, which provides real-time treatment for seizures.

What is the significance of the RNS System by NeuroPace?

The RNS System is the first commercially available, brain-responsive platform that delivers personalized treatment directly at the seizure source.

What stock symbol is NeuroPace associated with?

NeuroPace is traded under the stock symbol NPCE.